At a conference in Washington last week organized by the Personalized Medicine Coalition (PMC) and the Biotechnology Industry Organization (BIO, both of Washington DC), the world of diagnostics/pharma, clinician- and patient-interest groups, and payors met to discuss the commercialization directions of the companion diagnostics world.
Read More
